Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis

Tuberculosis

Volumn 89, Issue 6, 2009, Pages 405-416

  Sharpe, S A ^a   Eschelbach, E ^b   Basaraba, R J ^b   Gleeson, F ^c   Hall, G A ^a   McIntyre, A ^b   Williams, A ^a   Kraft, S L ^b   Clark, S ^a   Gooch, K ^a   Hatch, G ^a   Orme, I M ^b   Marsh, P D ^a   Dennis, M J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Non human primate; Pathology; Stereology; Tuberculosis

Indexed keywords

FORMALDEHYDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE CONCENTRATE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LUNG VOLUME; MACACA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEDIMENTATION RATE; STEREOLOGY; TEMPERATURE; THORAX RADIOGRAPHY; TUBERCULOSIS;

AEROSOLS; ANIMALS; DISEASE MODELS, ANIMAL; LUNG; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 71549144961     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2009.09.002     Document Type: Article

References (41)

1. Global tuberculosis control: surveillance, planning, financing: WHO report; 2008. WHO/htm/TB/2008.393.
2. Colditz G.A., Brewer T.F., Berkley M.E., Wilson E., Burdick H.V., Fineberg, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA 271 (1994) 698-702
3. Orme I.M., McMurray D.N., and Belisle J.T. Tuberculosis vaccine development: recent progress. Trends Microbiol 9 (2001) 115-118
4. Basaraba R.J. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 88 Suppl. 1 (2008 Aug) S35-S47 Review
5. McMurray D.N., Collins F.M., Dannenberg Jr. A.M., and Smith D.W. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 215 (1996) 157-179
6. McMurray D.N. A non-human primate model for the preclinical testing of new tubeculosis vaccines. Clin Infect Dis 30 Suppl. 3 (2000) S210-S212
7. Capuano S.V., Croix D.A., Pawar S., Zinovik A., Myers A., Lin P.L., et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun (2003) 5831-5844
8. Good R.C. Simian tuberculosis: immunologic aspects. Annals NY Acad Csi 154 (1968) 200-213
9. Barclay W.R., Anacker R.L., Brehmer W., Leif W., and Ribi E. Aerosol-induced tuberculosis in sub-human primates and the course of the disease after intravenous BCG vaccination. Infect Immun (1970) 574-582
10. Barclay W.R., Busey W.M., Dalgard D.W., Good R.C., Janicki B.W., Kasik J.E., et al. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis 107 3 (1973 Mar) 351-358
11. Janicki B.W., Good R.C., Minden P., Affronti L.F., and Hymes W.F. Immune responses in rhesus monkeys after bacille Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. Am Rev Respir Dis 107 (1973) 359-366
12. Chaparas S.D., Good R.C., and Janicki B.W. Tuberculin-induced lymphocyte transformation and skin reactivity monkeys vaccinated or not vaccinated with bacille Calmette-Guerin, then challenged with virulent Mycobacterium tuberculosis. Am Rev Respir Dis 112 (1975) 43-47
13. Kraft S.L., Dailey D., Kovach M., Stasiak K.L., Bennett J., McFarland C.T., et al. Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 72 10 (2004 Oct) 5963-5971
14. Langermans J.A.M., Anderson P., van Soolingen D., Verenne R.A.W., Frost P.A., van der Laan T., et al. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci USA 98 20 (2000) 11497-11502
15. Williams A., Davies A.C., Marsh P.D., Chambers M.A., and Hewinson R.G. Evaluation of the protective efficacy of Bacille Calmette-Guerin vaccination against aerosol challenge by M. tuberculosis and M. bovis. Clinical Infectious Diseases 30 Suppl. 3 (2000) S299-S301
16. Williams A., Reljic R., Naylor I., Clark S.O., Falero-diaz G., Singh M., et al. Passive protection with IgA antibodies against tuberculous early infection of the lungs. Immunology 111 (2004) 328-333
17. Williams A., James B.W., Bacon J., Hatch K.A., Hatch G.J., Hall G.A., et al. An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology. Tuberculosis 85 (2005) 177-184
18. Lever M.S., Williams A., and Bennett A.M. Survival of mycobacterial species in aerosols generated from artificial saliva. Letts Appl Microbial 31 (2000) 238-241
19. Druett H.A. A mobile form of the Henderson apparatus. J Hyg(Lond) 67 (1969) 437-448
20. Harper G.J., and Morton J.D. The respiratory retention of bacterial aerosols: experiments with radioactive spores. J Hyg (Lond) 51 (1953) 372-385
21. Langermans J.A.M., Doherty T.M., Verenne R.A.W., van der Laan T., Lyashchenko K., Greenwald R., et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT6. Vaccine 23 (2005) 270-275
22. Michel R.P., and Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc 150 Pt 2 (1988) 117-136
23. Cruz-Orive L.M., and Weibel E.R. Sampling designs for stereology. J Microsc 122 Pt 3 (1981) 235-257
24. Knust J., Ochs M., Gundersen H.J., and Nyengaard J.R. Stereological estimates of alveolar number and size and capillary length and surface area in mice lungs. Anat Rec (Hoboken) 292 1 (2009) 113-122
25. Nyengaard J.R., and Gundersen H.J.G. Sampling for stereology in lungs. Eur Respir Rev 15 101 (2006) 107-114
26. Lin P.L., Pawar S., Myers A., Pergu A., Fuhrman C., Reinhart T.A., et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 74 (2006) 3790-3803
27. Ribi E., Anacker R.L., Barclay W.R., Brehmer W., Harris S.C., Leif W.R., et al. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey. J Infect Dis 123 (1971) 527-538
28. Gormus B.J., Blanchard J.L., Alvarez X.H., and Didier P.J. Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 33 (2004) 134-145
29. Shen Y., Zhou D., Qiu L., Lai X., Simon M., Shen L., et al. Adaptive immune responses of Vγ2Vδ2 + T cells during mycobacterial infections. Science 295 (2002) 2255-2258
30. Walsh G.P., Tan E.V., dela Cruz E.C., Abalos R.M., Villahermosa L.G., Young L.J., et al. The Philippine cynomolgus monkey (Macca fasicularis) provides a new non-human primate model of tuberculosis that resembles human disease. Nat Med 2 (1996) 237-240
31. Lewinsohn D.M., Tydeman I.S., Frieder M., Grotzke J.E., Lines R.A., Ahmed S., et al. High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect 8 (2006) 2587-2598
32. Sugawara I., Li Z., Sun L., Udagawa T., and Taniyama T. Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (macaca fasicularis) infected with H37Rv Mycobacterium tuberculosis. Tuberculosis 87 (2007) 518-525
33. Reed S.G., Coler R.N., Dalemans W., Tan E.V., Dela Cruz E.C., Basaraba R.J., et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 106 (2009) 2301-2306
34. Lin P.L., Rodgers M., Smith L., Bigbee M., Myers A., Bigbee C., et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun (2009). iai.asm.org published on line ahead of print from
35. Basaraba R.J., Smith E.E., Shanley C.A., and Orme I.M. Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol. Infect Immun 74 (2006) 5397-5401
36. Palanisamy G.S., Smith E.E., Shanley C.A., Ordway D.J., Orme I.M., and Basaraba R.J. Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model. Tuberculosis (Edinb) 88 (2008) 295-306
37. Hyde D.M., Tyler N.K., and Plopper C.G. Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps. Toxicol Pathol 35 (2007) 41-48
38. Oberholzer M., Bianchi L., Dalquen P., Landmann L., and Heitz P.U. Stereology in the extraction of information from images. Anal Quant Cytol Histol 7 (1985) 197
39. Weibel E.R. Quantitation in morphology: possibilities and limits. Beitr Pathol 155 (1975) 1-17
40. Weibel E.R., Hsia C.C., and Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 102 1 (2007) 459-467
41. Verreck F.A.W., Vervenne R.A.W., Kondova I., van Kralingen K.W., Remarque E.J., Braskamp G., et al. MVA.85A boosting of BCG and an attenuated phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS ONE 4 (2009) e5264 1-11